Katherine Vandris

Recombinant interferon-α may retard progression of early primary myelofibrosis: a preliminary report

Richard T. Silver, Katherine Vandris, Joshua J. Goldman · Blood · 2011 · 136 citations

A 10-year follow-up of treatment outcomes in patients with early stage breast cancer and clinically negative axillary nodes treated with tangential breast irradiation following sentinel lymph node dissection or axillary clearance

A. Gabriella Wernicke, Robert L. Goodman, Bruce Turner et al. · Breast Cancer Research and Treatment · 2010 · 71 citations · Full text

Surgical Oncology, Breast Oncology, Radiation Therapy +8

JAK2V617F allele burden in polycythemia vera correlates with grade of myelofibrosis, but is not substantially affected by therapy

Richard T. Silver, Katherine Vandris, Y. Lynn Wang et al. · Leukemia Research · 2010 · 59 citations · Full text

Inflammation, Polycythemia Vera, Hematological Malignancy +7

Vismodegib (V), a hedgehog (HH) pathway inhibitor, combined with FOLFOX for first-line therapy of patients (pts) with advanced gastric and gastroesophageal junction (GEJ) carcinoma: A New York Cancer Consortium led phase II randomized study.

Deirdre Jill Cohen, Paul J. Christos, Hedy L. Kindler et al. · Journal of Clinical Oncology · 2013 · 36 citations

Gastroenterology, Pathology, Advanced Gastric +16

Decrease in JAK2V617F allele burden is not a prerequisite to clinical response in patients with polycythemia vera

Emil Kuriakose, Katherine Vandris, Y. Lynn Wang et al. · Haematologica · 2011 · 35 citations · Full text